Data / Form D filings / MDC - Verte Fund, LLC
MDC - Verte Fund, LLC: Form D filings
MDC - Verte Fund, LLC, a biotechnology company in Baltimore, MD, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on March 4, 2025, reports $1 million sold of an offering with no set size to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 W PRATT ST, STE 200, Baltimore, MD, 21201
- Phone
- (301) 651-4809
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1880432
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Amendment | Indefinite | $1,027,000 | 10 | Jul 26, 2021 | sec.gov | |
| Feb 5, 2024 | Amendment | Indefinite | $606,000 | 8 | Jul 26, 2021 | sec.gov | |
| Aug 26, 2021 | New notice | Indefinite | $6,000 | 3 | Jul 26, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Leonard Mills | Director | |
| Jonathan Pearl | Director | |
| Gil Blankenship | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Mar 3, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MDC - Verte Fund, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.